High Cost to Medicaid Programs For Off-Label Use of Antipsychotics

2
353

A study of 42 state Medicaid programs found that 58% of prescriptions for antipsychotics  were not for schizophrenia or bipolar disorder. Off-label prescribing was most prevalent among individuals under 21 years of age (76%) or over 65 (65%), as opposed to 49% for those between 21 and 64 years. The authors note that the medications are expensive and have limited evidence of effectiveness. Results are published in this month’s American Journal of Managed Care.

Article →

***

Mad in America hosts blogs by a diverse group of writers. These posts are designed to serve as a public forum for a discussion—broadly speaking—of psychiatry and its treatments. The opinions expressed are the writers’ own.

Previous articleAntipsychotic Polypharmacy Commonly Prescribed Ahead of Guidelines
Next articleWe Need Drugs
Kermit Cole
Kermit Cole is a licensed marriage and family therapist based in Santa Fe, New Mexico. He and his partner, Luisa Putnam, joined by their mutual interest in working with trauma and psychosis, studied Open Dialogue in Finland and Peer-supported Open Dialogue in the UK in order to practice and teach as a team. In 2011, they joined with Robert Whitaker to found the Mad in America website

2 COMMENTS

LEAVE A REPLY